Trial | NCT03291548  Report issue

Title

Quinoa Biscuit & CVD Risk Trial
Effect of a Quinoa-enriched Biscuit as Novel Food Product to Improve CVD Risk Markers in Older Adults: a Randomised Crossover Study

  • Phase

    N/A

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Study Participants

    40
Cardiovascular disease (CVD) is one of the most common chronic diseases in older populations, which has been increasing in line with rising overweight and obesity levels in recent years. Dietary intake is a major modifiable risk factor for CVD, and one such recommendation is to increase the intake of essential (omega-3) polyunsaturated fats in our diets, for example by consuming more oily fish. We know, however, from large population level dietary surveys, that many individuals within the United Kingdom (UK) population are not consuming enough oily fish. Therefore, alternative dietary sources of omega-3 polyunsaturated fats are required to help meet consumer needs.

Quinoa is a traditional Andean seed crop consumed in a similar fashion to staple cereal grains in Europe, and the popularity of quinoa has been growing worldwide because of its nutritional content and perceived healthiness. Quinoa contains a small amount of fat, but the ratio of omega-6 and omega-3 essential fats is more favourable in quinoa than in other plant oils. An opportunity therefore exists to incorporate quinoa flour into more frequently consumed food products (e.g. biscuits) as an alternative means of increasing consumers omega-3 intake.

The purpose of this study is to investigate the effect of consuming quinoa-enriched biscuits, compared to control, on markers of CVD risk over 4-weeks in older adults.
Study Started
Feb 13
2017
Primary Completion
Jun 19
2017
Study Completion
Jun 19
2017
Last Update
Sep 25
2017

Dietary Supplement Quinoa biscuit

2x15g biscuits per day for 28 consecutive days (4 weeks).

Dietary Supplement Control biscuit

2x15g biscuits per day for 28 consecutive days (4 weeks).

Quinoa Biscuit Experimental

The quinoa-enriched biscuits containing 7.11g quinoa flour.

Control biscuit Placebo Comparator

The placebo control biscuit: an iso-energetic, matched product in terms of appearance, taste, texture and smell.

Criteria 

Inclusion Criteria:

Free-living, apparently healthy adults
Aged 50-75 years at recruitment
Low fish consumers (<2 servings/wk)
Non-smokers
Not regularly consuming plant stanols

Exclusion Criteria:

Non-free-living adults
Aged <50 or >75 years at recruitment
Fish consumers (2 servings/wk or more)
Current smokers
Pregnant/lactating females
Coeliac disease, wheat intolerance or any other food allergy or intolerance that would prevent consumption of the biscuits
Currently taking any fish oil-containing supplement
Diagnosed with a chronic medical condition (such as diabetes; CVD autoimmune/ inflammatory disorders; cancer)
Prescribed cholesterol or blood pressure lowering medications
Daily consumption of plant stanols
No Results Posted